Original Research Article I Volume 3 I Issue 3 I 2015

Biological subtypes of breast cancer and their impact on recurrence and survival rates: Alexandria surgical oncology unit experience

Mostafa Elsayed, Ahmed Tarek, Tarek Elfayoumi

Biolife; 2015, 3(3), pp 722-729

DOI:https://doi.org/10.5281/zenodo.7297829

Abstract:

The effect of breast cancer molecular subtypes and treatment on survival, loco regional and distant recurrences were analyzed. Aiming to decrease the incidence of recurrence, continuous urgue exists about the optimal surgical decision (BCS or mastectomy) to breast cancer subtypes (Triple negative breast cancer and her2 enriched. Alexandria Surgical Oncology Unit Data base was used to identify eligible breast cancer patient. Female patients who were diagnosed and/or treated from January 2000 to December 2010 with primary, invasive, unilateral breast cancer at our hospital were included. A total of 664 patients made up the study population.

Keywords:

Biological subtypes, breast conservative surgery, modified radical mastectomy..

References:

  1. Elesawy, B.H, Abd EL hafez, A, Shawky Ael, A. and Arafa, M. 2014. Immunohistochemistry-based subtyping of breast carcinoma in Egyptian women: a clinicopathological study on 125 patients. Annals of diagnostic pathology. 18: 21-26.
  2. Carey, L.A, Perou, C.M, Livasy, C.A, Dressler, L.G, Cowan, D. and Conway, K, et al. 2006. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 295: 2492–2502.
  3. Perou, C.M, Sorlie, T, Eisen, M.B, van de Rijn, M, Jeffrey, SS. and Rees, C.A, et al. 2000. Molecular portraits of human breast tumours. Nature. 406: 747–752.
  4. Perou, C.M. and Borresen-Dale, A.L. 2011. Systems biology and genomics of breast cancer. Cold Spring Harb Perspect Biol. 3. pii: a003293.
  5. Blows, F.M, Driver, K.E, Schmidt, M.K, Broeks, A, van Leeuwen, F.E. and Wesseling J, et al. 2010. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 7: e1000279.
  6. Carey, L.A, Dees, E.C, Sawyer, L, Gatti, L, Moore, D.T. and Collichio, F, et al. 2007. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 13: 2329–2334.
  7. Millikan, R.C, Newman, B, Tse, C.K, Moorman, P.G, Conway, K. and Dressler, L.G, et al. 2008. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 109: 123–139.
  8. Chang, H.R, Glaspy, J, Allison, M.A, Kass, F.C, Elashoff, R. and Chung, D.U, et al.  2010. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment. Cancer. 116: 4227–4237.
  9. Yerushalmi, R, Hayes, M.M, Gelmon, K.A, Chia, S, Bajdik, C. and Norris, B, et al. 2009. A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers. Clin Breast Cancer. 9: 166–172.
  10. Gabos, Z, Thoms, J, Ghosh, S, Hanson, J, Deschenes, J. and Sabri, S, et al. 2010. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Res Treat. 124: 187–194.
  11. Santana-Davila, R. and Perez, E.A. 2010. Treatment options for patients with triplenegative breast cancer. J Hematol Oncol. 3: 42.
  12. Dawood, S. 2010. Triple-negative breast cancer: epidemiology and management options. Drugs. 70: 2247–2258...

Article Dates:

Received: 8 July 2015; Accepted: 24 August 2015; Published: 7 September 2015

How To Cite:

Mostafa Elsayed, Tarek Elfayoumi, & ATAwad. (2022). Biological subtypes of breast cancer and their impact on recurrence and survival rates: Alexandria surgical oncology unit experience. Biolife, 3(3), 722–729. https://doi.org/10.5281/zenodo.7297829

Download Full Paper: PDF
Submit Manuscript
Join as Reviewer / Editor

Logo


Logo